AI Assistant
Blog
Pricing
Log In
Sign Up
DOP029. Outcomes of a managed switching programme changing IBD patients established on originator infliximab to biosimilar infliximab
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
